Inside India’s plans for revamping clinical trials India’s drug regulator has issued draft guidelines that would require pharmaceutical companies conducting clinical trials in the country to provide more detailed information on outcomes and adhere to strict reporting timelines.
Inside India’s plans for revamping clinical trials
- Konuyu başlatan Bilgin
- Başlangıç tarihi